NIRMAN AGRI GENETICS Financial Statement Analysis
|
||
The Revenues of NIRMAN AGRI GENETICS have increased by 112.08% YoY .
The Earnings Per Share (EPS) of NIRMAN AGRI GENETICS has decreased by -99.74 % YoY. |
REVENUES |
OPERATING MARGIN |
PROFIT AFTER TAX |
EPS |
ROCE |
NIRMAN AGRI GENETICS Last 5 Annual Financial Results
[NSE : NIRMAN]
Standalone | Mar2023 | Mar2022 | Mar2021 |
---|---|---|---|
Revenues | ₹29 Cr | ₹13 Cr | ₹3.82 Cr |
Expenses | ₹24 Cr | ₹10 Cr | ₹3.75 Cr |
Operating Profit (Excl OI) | ₹4.36 Cr | ₹3.42 Cr | ₹0.07 Cr |
Other Income | ₹0.00 Cr | ₹0.00 Cr | ₹0.00 Cr |
Interest | ₹0.01 Cr | ₹0.00 Cr | ₹0.00 Cr |
Depreciation | ₹0.09 Cr | ₹0.00 Cr | ₹0.00 Cr |
Profit Before Tax | ₹4.26 Cr | ₹3.42 Cr | ₹0.07 Cr |
Profit After Tax | ₹4.01 Cr | ₹2.56 Cr | ₹0.06 Cr |
Consolidated Net Profit | ₹4.01 Cr | ₹2.56 Cr | ₹0.06 Cr |
Earnings Per Share (Rs) | ₹6.72 | ₹2,560.20 | ₹54.70 |
PAT Margin (%) | 14.00 | 18.98 | 1.43 |
ROE(%) | 27.06 | 189.03 | 84.54 |
ROCE(%) | 26.60 | 133.26 | 7.00 |
Total Debt/Equity(x) | 0.04 | 0.54 | 15.33 |
Key Financials |
||
Market Cap | : | ₹ 126.6 Cr |
Revenue (TTM) | : | ₹ 53.9 Cr |
Net Profit(TTM) | : | ₹ 9.0 Cr |
EPS (TTM) | : | ₹ 14.9 |
P/E (TTM) | : | 14.1 |
Industry Peers & Returns | 1W | 1M | 1Y |
NIRMAN AGRI GENETICS | -1.2% | NA | 123.5% |
BOMBAY BURMAH TRADING CORPORATION | 1.1% | 2.4% | 61.3% |
KAVERI SEED COMPANY | -0.3% | 23.7% | 66.4% |
VENKYS (INDIA) | 0.6% | 1.4% | 11.1% |
BOMBAY SUPER HYBRID SEEDS | 0.7% | -3.9% | -38.2% |
TIERRA AGROTECH | -18.5% | -25.3% | -54.6% |
INDO US BIOTECH | 5% | -12.5% | 180.3% |
NATH BIOGENES (INDIA) | 4.7% | 3.1% | 16.6% |
MANGALAM SEEDS | -0.1% | -0.6% | 59.6% |
NIRMAN AGRI GENETICS Revenues
[NSE : NIRMAN]
Y-o-Y | 112.08 % |
5 Yr CAGR | 173.59 % |
Years | Revenues | % Change | |
---|---|---|---|
Mar2023 | ₹29 Cr | 112.08 | |
Mar2022 | ₹13 Cr | 252.93 | |
Mar2021 | ₹3.82 Cr | - |
NIRMAN AGRI GENETICS Operating Profit
[NSE : NIRMAN]
Y-o-Y | 27.42 % |
5 Yr CAGR | 667.85 % |
Years | Operating Profit | % Change | |
---|---|---|---|
Mar2023 | ₹4.36 Cr | 27.42 | |
Mar2022 | ₹3.42 Cr | 4,527.03 | |
Mar2021 | ₹0.07 Cr | - |
Operating Margins | |
---|---|
Y-o-Y | -39.91 % |
5 Yr CAGR | 180.37 % |
Years | Operating Margin% | % Change | |
---|---|---|---|
Mar2023 | 15.25% | -39.91 | |
Mar2022 | 25.38% | 1,208.25 | |
Mar2021 | 1.94% | - |
NIRMAN AGRI GENETICS Profit After Tax
[NSE : NIRMAN]
Y-o-Y | 56.45 % |
5 Yr CAGR | 753.34 % |
Years | Profit After Tax | % Change | |
---|---|---|---|
Mar2023 | ₹4.01 Cr | 56.45 | |
Mar2022 | ₹2.56 Cr | 4,554.55 | |
Mar2021 | ₹0.06 Cr | - |
PAT Margins | |
---|---|
Y-o-Y | -26.24 % |
5 Yr CAGR | 212.89 % |
Years | PAT Margin(%) | % Change | |
---|---|---|---|
Mar2023 | 14 % | -26.24 | |
Mar2022 | 18.98 % | 1,227.27 | |
Mar2021 | 1.43 % | - |
NIRMAN AGRI GENETICS Earnings Per Share (EPS)
[NSE : NIRMAN]
Y-o-Y | -99.74 % |
5 Yr CAGR | -64.95 % |
Years | EPS | % Change | |
---|---|---|---|
Mar2023 | ₹6.72 | -99.74 | |
Mar2022 | ₹2,560 | 4,580.44 | |
Mar2021 | ₹55 | - |
NIRMAN AGRI GENETICS Return on Capital Employed (ROCE)
[NSE : NIRMAN]
Y-o-Y | -80.04 % |
5 Yr CAGR | 94.94 % |
Years | ROCE | % Change | |
---|---|---|---|
Mar2023 | 26.6% | -80.04 | |
Mar2022 | 133.26% | 1,803.71 | |
Mar2021 | 7% | - |
NIRMAN AGRI GENETICS Share Price vs Sensex
Current Share Price | : | ₹211.0 |
Current MarketCap | : | ₹ 126.6 Cr |
Updated EOD on | : | May 18,2024 |
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
NIRMAN AGRI GENETICS | -1.2% |
NA |
123.5% |
SENSEX | 1.7% |
1.5% |
18.7% |
NIRMAN AGRI GENETICS related INDICES
You may also like the below Video Courses
FAQ about NIRMAN AGRI GENETICS Financials
How the annual revenues of NIRMAN AGRI GENETICS have changed ?
The Revenues of NIRMAN AGRI GENETICS have increased by 112.08% YoY .
How the Earnings per Share (EPS) of NIRMAN AGRI GENETICS have changed?
The Earnings Per Share (EPS) of NIRMAN AGRI GENETICS has decreased by -99.74 % YoY .
BOMBAY BURMAH TRADING CORPORATION LTD vs KAVERI SEED COMPANY LTD vs VENKYS (INDIA) LTD
BOMBAY SUPER HYBRID SEEDS LTD vs TIERRA AGROTECH LTD vs